Herpesviridae

May 11, 2020

HKBU-led Research Team Develops Novel Anti-viral Targeted Drug for Nasopharyngeal Cancer Treatment

Oct 29, 2019

Market Share in Nanotechnology and Nanomedicine for Treatment of Viral Infections Could Reach Tens of Billion Dollars

Aug 26, 2019

NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND

Jul 08, 2019

Alzheimer's disease virus research spotlighted at HHV-6 conference, reports Dr. Leslie Norins of Alzheimer's Germ Quest, Inc.

Apr 16, 2019

NanoViricides Submits Pre-IND Briefing Documents to the US FDA

Mar 26, 2019

NanoViricides has Requested a Pre-IND Meeting with the US FDA

Feb 27, 2019

NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering

Jan 14, 2019

Saol Therapeutics Announces CDC has Updated Information Related to Use and Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human])

Sep 28, 2018

NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1

Sep 05, 2018

NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th

Jun 26, 2017

NanoViricides' Poster "Novel Nanoviricides® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented Today at the 2017 Annual Meeting of American Society of Virology

Jun 20, 2017

NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology